ProBiotix Health Plc (AQU:PBX)
London
· Delayed Price · Currency is GBP · Price in GBX 8.50
0.00 (0.00%)
At close: Apr 16, 2025
ProBiotix Health Revenue
ProBiotix Health had revenue of 1.01M GBP in the half year ending June 30, 2024, with 233.11% growth. This brings the company's revenue in the last twelve months to 2.13M, up 70.65% year-over-year. In the year 2023, ProBiotix Health had annual revenue of 1.67M with 49.19% growth.
Revenue (ttm)
2.13M
Revenue Growth
+70.65%
P/S Ratio
6.32
Revenue / Employee
303.86K
Employees
7
Market Cap
13.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.67M | 551.62K | 49.19% |
| Dec 31, 2022 | 1.12M | 21.25K | 1.93% |
| Dec 31, 2021 | 1.10M | 279.01K | 33.98% |
| Dec 31, 2020 | 821.13K | 453.90K | 123.60% |
| Dec 31, 2019 | 367.23K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| Shell | 227.10B |
| HSBC Holdings | 48.93B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| British American Tobacco p.l.c. | 25.87B |
| London Stock Exchange Group | 8.86B |